Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of “Buy” by Brokerages

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have been given an average rating of “Buy” by the sixteen research firms that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, twelve have given a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $24.80.

A number of research analysts recently commented on PRVA shares. JPMorgan Chase & Co. raised their price objective on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Friday, November 29th. KeyCorp started coverage on shares of Privia Health Group in a research report on Friday, October 11th. They set an “overweight” rating and a $23.00 price target for the company. Macquarie assumed coverage on shares of Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target on the stock. Truist Financial increased their price target on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Finally, Robert W. Baird boosted their price objective on Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 26th.

Institutional Investors Weigh In On Privia Health Group

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Canada Pension Plan Investment Board bought a new position in Privia Health Group during the 2nd quarter valued at $26,000. Nisa Investment Advisors LLC boosted its stake in Privia Health Group by 107.5% during the second quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after buying an additional 930 shares in the last quarter. GAMMA Investing LLC grew its holdings in Privia Health Group by 98.7% during the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock worth $31,000 after acquiring an additional 845 shares during the period. Signaturefd LLC raised its position in Privia Health Group by 46.3% in the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after acquiring an additional 626 shares in the last quarter. Finally, Quarry LP lifted its holdings in Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after acquiring an additional 2,533 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Price Performance

Shares of Privia Health Group stock opened at $20.07 on Friday. Privia Health Group has a 1-year low of $15.92 and a 1-year high of $24.30. The company has a market capitalization of $2.41 billion, a PE ratio of 200.72, a P/E/G ratio of 5.45 and a beta of 0.83. The business has a 50-day moving average of $20.30 and a 200-day moving average of $19.13.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.